Arizona State Retirement System’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$102K Buy
+10,335
New +$86.4K ﹤0.01% 2053
2024
Q3
Sell
-7,510
Closed -$100K 2155
2024
Q2
$100K Buy
7,510
+278
+4% +$8.29K ﹤0.01% 2047
2024
Q1
$336K Sell
7,232
-41
-0.6% -$2.12K ﹤0.01% 1664
2023
Q4
$492K Sell
7,273
-62
-0.8% -$3.8K ﹤0.01% 1453
2023
Q3
$531K Buy
7,335
+720
+11% +$57.6K ﹤0.01% 1344
2023
Q2
$492K Buy
6,615
+547
+9% +$32.4K ﹤0.01% 1419
2023
Q1
$323K Buy
6,068
+280
+5% +$17.7K ﹤0.01% 1664
2022
Q4
$391K Buy
5,788
+1,702
+42% +$157K ﹤0.01% 1511
2022
Q3
$510K Buy
4,086
+60
+1% +$7.15K 0.01% 1308
2022
Q2
$383K Buy
+4,026
New +$491K ﹤0.01% 1523

Other funds holding DNA

Arizona State Retirement System's DNA Position: Q2 2026 in Review

Arizona State Retirement System opened a new position in Ginkgo Bioworks (DNA) in Q2 2026: 10,335 shares worth $102K. The stake represents ﹤0.01% of the portfolio and ranks #2053 among its holdings. This is a return to the name: Arizona State Retirement System previously reported a position in DNA as recently as Q2 2024.

Arizona State Retirement System first reported a position in DNA in Q2 2022 and has held it in 10 quarters since. The position peaked at $531K in Q3 2023. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Arizona State Retirement System held 10,335 shares of Ginkgo Bioworks worth $102K as of Q2 2026.
  • Ginkgo Bioworks was a new Arizona State Retirement System position in Q2 2026.
  • Ginkgo Bioworks made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #2053 holding.
  • Arizona State Retirement System first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 10 quarters since.
  • Arizona State Retirement System's Ginkgo Bioworks position peaked at $531K in Q3 2023.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.